The decrease of these cytokines reduces the liver damage and the progression of hepatic fibrosis, since IL-1β is related to the amplification of the inflammatory process and contributes to the secretion of profibrogenic cytokine TGF-β, which promotes the activation of hepatic stellate cells. This evidence concerns the gene TGFB1 and Hepatic fibrosis.